Background/Aim: Phenotype-driven screening of a great pool of randomly mutant mice and subsequent selection of animals showing symptoms equivalent to human kidney diseases may result in the generation of novel suitable models for the study of the pathomechanisms and the identification of genes involved in kidney dysfunction. Methods: We carried out a large-scale analysis of ethylnitrosourea (ENU)-induced mouse mutants for albuminuria by using qualitative SDS-polyacrylamide gel electrophoresis. Results: The primary albuminuria screen preceded the comprehensive phenotypic mutation analysis in a part of the mice of the Munich ENU project to avoid loss of mutant animals as a consequence of prolonged suffering from severe nephropathy. The primary screen detected six confirmed phenotypic variants in 2,011 G1 animals screened for dominant mutations and no variant in 48 G3 pedigrees screened for recessive mutations. Further breeding experiments resulted in two lines showing a low phenotypic penetrance of albuminuria. The secondary albuminuria screen was carried out in mutant lines which were established in the Munich ENU project without preceding primary albuminuria analysis. Two lines showing increased plasma urea levels were chosen to clarify if severe kidney lesions are involved in the abnormal phenotype. This analysis revealed severe albuminuria in mice which are affected by a recessive mutation leading to increased plasma urea and cholesterol levels. Conclusion: Thus, the phenotypic selection of ENU-induced mutants according to the parameter proteinuria in principle demonstrates the feasibility to identify nephropathy phenotypes in ENU-mutagenized mice.

1.
Brown SD, Balling R: Systematic approaches to mouse mutagenesis. Curr Opin Genet Dev 2001;11:268–273.
[PubMed]
2.
Silver LM: Mouse Genetics: Concepts and Applications. New York, Oxford University Press, 1995.
3.
Russ A, Stumm G, Augustin M, Sedlmeier R, Wattler S, Nehls M: Random mutagenesis in the mouse as a tool in drug discovery. Drug Discov Today 2002;7:1175–1183.
[PubMed]
4.
Hrabe de Angelis MH, Flaswinkel H, Fuchs H, Rathkolb B, Soewarto D, Marschall S, Heffner S, Pargent W, Wuensch K, Jung M, Reis A, Richter T, Alessandrini F, Jakob T, Fuchs E, Kolb H, Kremmer E, Schaeble K, Rollinski B, Roscher A, Peters C, Meitinger T, Strom T, Steckler T, Holsboer F, Klopstock T, Gekeler F, Schindewolf C, Jung T, Avraham K, Behrendt H, Ring J, Zimmer A, Schughart K, Pfeffer K, Wolf E, Balling R: Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet 2000;25:444–447.
[PubMed]
5.
Rathkolb B, Decker T, Fuchs E, Soewarto D, Fella C, Heffner S, Pargent W, Wanke R, Balling R, Hrabe de Angelis M, Kolb HJ, Wolf E: The clinical-chemical screen in the Munich ENU Mouse Mutagenesis Project: Screening for clinically relevant phenotypes. Mamm Genome 2000;11:543–546.
[PubMed]
6.
Rathkolb B, Fuchs E, Kolb HJ, Renner-Muller I, Krebs O, Balling R, Hrabe de Angelis M, Wolf E: Large-scale N-ethyl-N-nitrosourea mutagenesis of mice – From phenotypes to genes. Exp Physiol 2000;85:635–644.
[PubMed]
7.
Saborio P, Scheinman J: Genetic renal disease. Curr Opin Pediatr 1998;10:174–183.
[PubMed]
8.
D’Amico G, Bazzi C: Pathophysiology of proteinuria. Kidney Int 2003;63:809–825.
[PubMed]
9.
Klahr S, Morrissey J: Progression of chronic renal disease. Am J Kidney Dis 2003;41:S3–S7.
[PubMed]
10.
Tryggvason K, Pettersson E: Causes and consequences of proteinuria: The kidney filtration barrier and progressive renal failure. J Intern Med 2003;254:216–224.
[PubMed]
11.
Beynon RJ, Hurst JL: Multiple roles of major urinary proteins in the house mouse, Mus domesticus. Biochem Soc Trans 2003;31:142–146.
[PubMed]
12.
Loeb WF, Quimby FW: The Clinical Chemistry of Laboratory Animals. Philadelphia, Taylor & Francis, 1999.
13.
Doi T, Striker LJ, Gibson CC, Agodoa LY, Brinster RL, Striker GE: Glomerular lesions in mice transgenic for growth hormone and insulin-like growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis. Am J Pathol 1990;137:541–552.
[PubMed]
14.
Wolf E, Wanke R: Growth hormone overproduction in transgenic mice: Phenotypic alterations and deduced animal models; in van Zutphen LFM, van der Meer M (eds): Welfare of Transgenic Animals. Heidelberg, Springer, 1997, pp 26–47.
15.
Anders H, Schlondorff D: Murine models of renal disease: Possibilities and problems in studies using mutant mice. Exp Nephrol 2000;8:181–193.
[PubMed]
16.
Paigen K, Eppig JT: A mouse phenome project. Mamm Genome 2000;11:715–717.
[PubMed]
17.
Terzi F, Burtin M, Friedlander G: Using transgenic mice to analyze the mechanisms of progression of chronic renal failure. J Am Soc Nephrol 2000;11(suppl 16):144–148.
18.
Korstanje R, DiPetrillo K: Unraveling the genetics of chronic kidney disease using animal models. Am J Physiol Renal Physiol 2004;287:F347–F352.
19.
Sadl V, Jin F, Yu J, Cui S, Holmyard D, Quaggin S, Barsh G, Cordes S: The mouse Kreisler (Krml1/MafB) segmentation gene is required for differentiation of glomerular visceral epithelial cells. Dev Biol 2002;249:16–29.
[PubMed]
You do not currently have access to this content.